Friday, November 22, 2024

Mumbai couple gets Rs 15.31 crore from anonymous donor for treatment of 16-month-old son

The child was diagnosed with spinal muscular atrophy (SMA) type 2, a rare disease for which a key one-time drug costs almost Rs 17.3 crore

Mumbai: A Mumbai  couple who recently shifted to Kerala, has received Rs 15.31 crore from an anonymous donor to purchase a life-saving drug for the treatment of their 16-month-old son, a PTI report in The Tribune, Chandigarh, says.

Marine Engineer Sarang Menon and Adithi Nair’s son Nirvaan was diagnosed with spinal muscular atrophy (SMA) type 2, a rare disease for which a key one-time drug costs almost Rs 17.3 crore.

Donations began pouring after a crowdfunding page was started on Milaap.org, but the identity of the person who gave USD 1.4 million, or Rs 15.31 crore, is unknown, Nair told PTI.

The target set by Menon when the crowdfunding page began was Rs 17.50 crore.

“We are happy this contribution has taken us very close to our target. I think we will manage to raise the remaining amount on our own as well as through relatives and friends,” she said.

“However, it will take at least 2-3 weeks for us to take Nirvaan back to Mumbai due to some mandatory testing and the time required for the arrival of the drug from the US to Mumbai,” Nair added

The family has already initiated required communication with the Union finance ministry and import-export department for necessary clearances for the drug.

Dr Neelu Desai, paediatric neurologist at Hinduja Hospital will be treating Nirvaan.

SMA is a group of ailments in which specialised nerve cells in the brain and spinal cord, also called motor neurons, that control movement in the arms, legs, face, throat, tongue get destroyed  in a progressive degenerative process.

**************************************************************

Readers

These are extraordinary times. All of us have to rely on high-impact, trustworthy journalism. And this is especially true of the Indian Diaspora. Members of the Indian community overseas cannot be fed with inaccurate news.

Pravasi Samwad is a venture that has no shareholders. It is the result of an impassioned initiative of a handful of Indian journalists spread around the world.  We have taken the small step forward with the pledge to provide news with accuracy, free from political and commercial influence. Our aim is to keep you, our readers, informed about developments at ‘home’ and across the world that affect you.

Please help us to keep our journalism independent and free.

In these difficult times, to run a news website requires finances. While every contribution, big or small, will makes a difference, we request our readers to put us in touch with advertisers worldwide. It will be a great help.

For more information: pravasisamwad00@gmail.com

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

EDITOR'S CHOICE